Aashka Hospitals Limited (BOM:543346)
India · Delayed Price · Currency is INR 79.90
-0.10 (-0.12%)
At close: Feb 1, 2026
Aashka Hospitals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 207.26 | 226.47 | 228.74 | 189.45 | 397.34 | 406.89 | |
Revenue Growth (YoY) | -15.18% | -0.99% | 20.74% | -52.32% | -2.35% | 49.44% |
Cost of Revenue | 75.15 | 69.41 | 67.92 | 68.47 | 124.51 | 292.26 |
Gross Profit | 132.11 | 157.06 | 160.82 | 120.98 | 272.82 | 114.63 |
Selling, General & Admin | 3.29 | 3.29 | 4.53 | 3.9 | 1.24 | 6.2 |
Other Operating Expenses | 104.21 | 105.46 | 111.56 | 113.55 | 185.87 | 8.79 |
Operating Expenses | 135.72 | 138.21 | 145.28 | 146.8 | 216.11 | 41.05 |
Operating Income | -3.61 | 18.86 | 15.54 | -25.82 | 56.71 | 73.58 |
Interest Expense | -11.06 | -14.99 | -25.81 | -29.79 | -27.63 | -30.9 |
Interest & Investment Income | 23.05 | 23.05 | 41.18 | 30.86 | 0.18 | 0.04 |
Other Non Operating Income (Expenses) | 4.92 | 2.52 | -2.33 | -0.94 | -1.2 | -1.57 |
EBT Excluding Unusual Items | 13.29 | 29.44 | 28.58 | -25.69 | 28.06 | 41.14 |
Gain (Loss) on Sale of Assets | - | - | -0.11 | - | - | - |
Other Unusual Items | 15.22 | 9.26 | - | - | - | - |
Pretax Income | 28.51 | 38.7 | 28.46 | -25.69 | 28.39 | 41.14 |
Income Tax Expense | 4.24 | 6.04 | 4.88 | - | 4.74 | - |
Net Income | 24.28 | 32.66 | 23.58 | -25.69 | 23.65 | 41.14 |
Net Income to Common | 24.28 | 32.66 | 23.58 | -25.69 | 23.65 | 41.14 |
Net Income Growth | -31.65% | 38.52% | - | - | -42.51% | 198.30% |
Shares Outstanding (Basic) | 23 | 23 | 23 | 23 | 21 | 18 |
Shares Outstanding (Diluted) | 23 | 23 | 23 | 23 | 21 | 18 |
Shares Change (YoY) | 0.66% | - | - | 10.58% | 17.59% | 1.09% |
EPS (Basic) | 1.03 | 1.40 | 1.01 | -1.10 | 1.12 | 2.29 |
EPS (Diluted) | 1.03 | 1.40 | 1.01 | -1.10 | 1.12 | 2.29 |
EPS Growth | -32.10% | 38.52% | - | - | -51.11% | 195.08% |
Free Cash Flow | 37.07 | 78.11 | 65.04 | 9.37 | -645.02 | 65.25 |
Free Cash Flow Per Share | 1.58 | 3.34 | 2.78 | 0.40 | -30.52 | 3.63 |
Gross Margin | 63.74% | 69.35% | 70.30% | 63.86% | 68.66% | 28.17% |
Operating Margin | -1.74% | 8.33% | 6.79% | -13.63% | 14.27% | 18.08% |
Profit Margin | 11.71% | 14.42% | 10.31% | -13.56% | 5.95% | 10.11% |
Free Cash Flow Margin | 17.89% | 34.49% | 28.43% | 4.94% | -162.34% | 16.04% |
EBITDA | 24.61 | 48.31 | 44.72 | 3.52 | 85.71 | 99.64 |
EBITDA Margin | 11.87% | 21.33% | 19.55% | 1.86% | 21.57% | 24.49% |
D&A For EBITDA | 28.22 | 29.46 | 29.18 | 29.34 | 29 | 26.06 |
EBIT | -3.61 | 18.86 | 15.54 | -25.82 | 56.71 | 73.58 |
EBIT Margin | -1.74% | 8.33% | 6.79% | -13.63% | 14.27% | 18.08% |
Effective Tax Rate | 14.86% | 15.60% | 17.16% | - | 16.69% | - |
Revenue as Reported | 243.04 | 259.85 | 270.9 | 220.48 | 398.61 | 406.92 |
Advertising Expenses | - | - | - | 3.63 | 0.47 | 0.65 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.